Substrate Oxidation: Clinical Trials

1 trial for Substrate Oxidation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Substrate Oxidation: new trials by email Literature Review of Substrate Oxidation trials Research Report on Substrate Oxidation

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation
Dapagliflozin 10mg, Placebo matching to Dapagliflozin 10 mg - Prediabetic State, Substrate Oxidation
Phase 4CompletedMaastricht University162019-04-302021-08-19

Narrower conditions

Prediabetic State (1)

Broader conditions

Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

dapagliflozin (1)

Sponsors

Maastricht University (1)

Countries

Netherlands (1)

Top investigators

Patrick Schrauwen, Prof. dr. (1)

Results publications

PMID 36592688